fludarabine

Ukraine

Drugs containing this active substance

  • FLUDARABINE ACCORD

    The drug is intended for the treatment of B-cell chronic lymphocytic leukemia in adult patients with adequate bone marrow reserve.

    Form: solution for injection, concentrate

    Active substance Dosage
    fludarabine 25 mg/ml

    ATC: L01BB05

    Manufacturer: Accord Healthcare Limited (additional secondary packaging)

  • The drug is intended for the treatment of B-cell chronic lymphocytic leukemia in patients with adequate bone marrow reserve.

    Form: powder for solution for injection or infusion

    Active substance Dosage
    fludarabine 50 mg

    ATC: L01BB05

    Manufacturer: Syndan Pharma S.R.L.